SHL TELEMEDICINE LTD Income Statement

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Revenues
Cost of revenues
Gross profit
Research and development costs
Selling and marketing expenses
General and administrative expenses
Other expenses
Operating loss
Financial income
Financial expenses
Profit (loss) before taxes on income
Tax expenses
Net profit (loss)
Comprehensive income (loss) attributable to:
Equity holders of the Company
Non-controlling interests
Other comprehensive income:
Re-measurement gain on defined benefit plans
Other comprehensive income (loss) to be reclassified to profit or loss in subsequent periods:
Foreign currency translation reserve
Total other comprehensive income
Total comprehensive loss
Earnings per share:
Basic loss
Diluted loss
Net profit (loss) attributable to:
Equity holders of the Company
Non-controlling interests

Comments